Harvard Apparatus Regenerative Technology Inc. (HRGN) Fair Value 2026

HRGN · Packaged Foods ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.3 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (35/100)

Quick Summary — As of 2026-08-27, Harvard Apparatus Regenerative Technology Inc. (HRGN) trades at $1.58. QOC: 5.3/10. Value Trap Risk: 35/100 (LOW). 1/13 models active.

Key Facts

Ticker
HRGN
Price
$1.58
Quality Score
5.3/10
Value Trap Risk
35/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

What Fair Value Does Each Model Give HRGN?

1 Intrinsic Value Models vs. Current Price ($1.58)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $0.60 -61.9%

All Models Active

All 1 models are displayed above.

What Is Harvard Apparatus Regenerative Technology Inc. (HRGN) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Harvard Apparatus Regenerative Technology Inc.'s intrinsic value is estimated at $0.60, suggesting the stock is overvalued at its current price of $1.58. With 1 out of 1 models flagging downside (-61.9% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About HRGN?

1 of 13 models are currently active for HRGN. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does HRGN Rank in Packaged Foods?

Among 81 Packaged Foods stocks, HRGN ranks #55 by Quality of Company score. CirclFi's QOC score of 5.3/10 evaluates 32 fundamental signals. A score of 5.3 reflects mixed fundamentals.

See all Most Undervalued Packaged Foods Stocks →

Within the Packaged Foods space, Harvard Apparatus Regenerative Technology Inc. competes in an environment where customer lifetime value (CLV) often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is HRGN a Value Trap?

CirclFi's Value Trap algorithm assigns HRGN a score of 35/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Harvard Apparatus Regenerative Technology Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Harvard Apparatus Regenerative Technology Inc. is rated at 5.3/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HRGN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HRGN's 1 active models, average confidence is 50%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Harvard Apparatus Regenerative Technology Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Packaged Foods Stocks Should You Also Analyze?

11 related Packaged Foods stocks with 13-model coverage

COOTAustralian Oilseeds Holdings LimitedQOC 5.4BOFBranchOut Food Inc.QOC 5.2RTONRight On Brands, Inc.QOC 5.4CLNNClene Inc.QOC 5.1ENHAEnhanced Group Inc.QOC 5.4MEHAFunctional Brands Inc.QOC 5.1BSFCBlue Star Foods Corp.QOC 3.3FTLFFitLife Brands, Inc.QOC 8.2BRIDBridgford Foods CorporationQOC 6.4PPCPilgrim's Pride CorporationQOC 9.0JJSFJ&J Snack Foods Corp.QOC 8.9

Read investment analysis: COOT · BOF · RTON · CLNN · ENHA · MEHA · BSFC · FTLF · BRID · PPC · JJSF

Which Other Stocks Have a Similar Quality Score to HRGN?

7 companies across all industries closest to HRGN’s Quality of Company score of 5.3/10.

QSJCTancheng Group Co., Ltd.QOC 5.3NUAINew Era Energy & Digital, Inc.QOC 5.3ACOGAlpha Cognition Inc. Common StockQOC 5.3TOROToro Corp.QOC 5.3PMAXPowell Max LimitedQOC 5.3LOOPLoop Industries, Inc.QOC 5.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: QSJC · NUAI · ACOG · TORO · PMAX · LOOP · NVDA

Where Does HRGN Sit in CirclFi's Packaged Foods Rankings?

HRGN is ranked against every other Packaged Foods stock CirclFi covers in each of these screens.

See all Packaged Foods stocks ranked →

What Else Do Investors Ask About Harvard Apparatus Regenerative Technology Inc.’s Valuation?

What is Harvard Apparatus Regenerative Technology Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Harvard Apparatus Regenerative Technology Inc. (HRGN). The Quality of Company score is 5.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HRGN overvalued or undervalued right now?

At $1.58, 0 of 1 active models suggest HRGN may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits Harvard Apparatus Regenerative Technology Inc.'s business model in Packaged Foods.

What does a Quality of Company score of 5.3 mean for HRGN?

Harvard Apparatus Regenerative Technology Inc.'s QOC of 5.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on HRGN?

CirclFi analyzes HRGN with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is HRGN a value trap in 2026?

Harvard Apparatus Regenerative Technology Inc.'s Value Trap score is 35/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Harvard Apparatus Regenerative Technology Inc. (HRGN) a Quality of Company score of 5.3/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/HRGN/ · Methodology
Primary sources for this HRGN valuation

Market data for HRGN as of ; valuations recomputed .